Praying for PYC to have favor with the FDA who have only had a handful of CPP-PMO IND before them, and probably the first ocular application of this nature.
Rohan uses the word “white space” this applies to both the science, regulatory and patient market = new frontier to be forged, and potentially usher in a unique leadership role for PYC to play in this new corner of the biotech-pharma industry.
as a side note, I noticed 17c strike price for new options; this is comforting for me as it indicates management internal valuation - am not sure how long the current 60% discount to previous cap raise price will persist - it’s a great deal for beneficiaries.
I do hope to breakeven on this tranche once FDA approves, not that I’ll be selling - but it also provides great motivation as these options for employees can go to being $1 in the moment I believe if all three programs make receive IND, and VP-001 show some efficacy which enhances look through valuation for the pipeline.
- Forums
- ASX - By Stock
- The Attractions of PYC's pipeline
Praying for PYC to have favor with the FDA who have only had a...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $513.2M |
Open | High | Low | Value | Volume |
10.0¢ | 11.0¢ | 10.0¢ | $184.6K | 1.761M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 51807 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 680221 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 51807 | 0.105 |
8 | 448234 | 0.100 |
2 | 711139 | 0.099 |
3 | 160000 | 0.098 |
2 | 105176 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 632221 | 4 |
0.115 | 1298747 | 6 |
0.120 | 590289 | 5 |
0.125 | 366111 | 3 |
0.130 | 325594 | 5 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |